治疗骨关节炎和椎间盘退化的细胞重编程策略
Zhengfa Jiang1, Chen Cao2,3, Yuhao Zhang1
1Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Aging and disease
|February 20, 2024
概括
细胞重编程为治疗骨关节炎 (OA) 和椎间盘退化 (IVDD) 提供了一个有希望的新途径,通过恢复细胞多能性. 需要进一步的研究,以探索其在再生医学中的全部潜力,以治疗这些常见的骨和关节疾病.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 骨关节炎 (OA) 和椎间盘退化 (IVDD) 是普遍存在的骨和关节退行性疾病,导致慢性疼痛和残疾.
- 目前对OA和IVDD的治疗方法有限,这引发了对再生医学方法的兴趣.
- 细胞重编程技术提供了一种新的策略,可以恢复细胞多能性,并可能治疗退行性骨关节病.
研究的目的:
- 介绍细胞重编程的特征.
- 总结有关OA和IVDD的病理机制,包括能量代谢,衰老,炎症,氧化应激和免疫失衡.
- 突出重编程衍生细胞在OA和IVDD治疗中的优势,而不是传统的细胞来源,如胚胎干细胞和介质干细胞.
主要方法:
- 对细胞重编程特征和机制的审查.
- 对OA和IVDD中可接受重新编程的病理途径的分析.
- 在OA和IVDD的背景下对重编程衍生细胞与干细胞进行比较评估.
主要成果:
- 细胞重编程可以解决OA和IVDD的关键病理机制,例如改善能量代谢和减少炎症.
- 与胚胎干细胞和介质干细胞相比,重编程衍生细胞在OA和IVDD的再生应用中具有显著的优势.
- 这项研究为开发用于OA和IVDD细胞重编程临床应用的策略提供了基础.
结论:
- 细胞重编程对OA和IVDD的个性化治疗有很大的希望,提供组织再生和修复.
- 尽管处于初步阶段,但重编程技术为治疗退行性骨和关节疾病开辟了一个新时代.
- 进一步的研究和战略开发对于OA和IVDD细胞重编程的临床转化至关重要.
相关概念视频
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:17Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
01:14Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K